The role of SPINK1 in ETS rearrangement-negative prostate cancers.

ETS gene fusions have been characterized in a majority of prostate cancers; however, the key molecular alterations in ETS-negative cancers are unclear. Here we used an outlier meta-analysis (meta-COPA) to identify SPINK1 outlier expression exclusively in a subset of ETS rearrangement-negative cancer...

Full description

Bibliographic Details
Main Authors: Tomlins, SA, Rhodes, DR, Yu, J, Varambally, S, Mehra, R, Perner, S, Demichelis, F, Helgeson, B, Laxman, B, Morris, D, Cao, Q, Cao, X, Andrén, O, Fall, K, Johnson, L, Wei, J, Shah, R, Al-Ahmadie, H, Eastham, J, Eggener, SE, Fine, S, Hotakainen, K, Stenman, U, Tsodikov, A, Gerald, W
Format: Journal article
Language:English
Published: 2008
_version_ 1797074386592727040
author Tomlins, SA
Rhodes, DR
Yu, J
Varambally, S
Mehra, R
Perner, S
Demichelis, F
Helgeson, B
Laxman, B
Morris, D
Cao, Q
Cao, X
Andrén, O
Fall, K
Johnson, L
Wei, J
Shah, R
Al-Ahmadie, H
Eastham, J
Eggener, SE
Fine, S
Hotakainen, K
Stenman, U
Tsodikov, A
Gerald, W
author_facet Tomlins, SA
Rhodes, DR
Yu, J
Varambally, S
Mehra, R
Perner, S
Demichelis, F
Helgeson, B
Laxman, B
Morris, D
Cao, Q
Cao, X
Andrén, O
Fall, K
Johnson, L
Wei, J
Shah, R
Al-Ahmadie, H
Eastham, J
Eggener, SE
Fine, S
Hotakainen, K
Stenman, U
Tsodikov, A
Gerald, W
author_sort Tomlins, SA
collection OXFORD
description ETS gene fusions have been characterized in a majority of prostate cancers; however, the key molecular alterations in ETS-negative cancers are unclear. Here we used an outlier meta-analysis (meta-COPA) to identify SPINK1 outlier expression exclusively in a subset of ETS rearrangement-negative cancers ( approximately 10% of total cases). We validated the mutual exclusivity of SPINK1 expression and ETS fusion status, demonstrated that SPINK1 outlier expression can be detected noninvasively in urine, and observed that SPINK1 outlier expression is an independent predictor of biochemical recurrence after resection. We identified the aggressive 22RV1 cell line as a SPINK1 outlier expression model and demonstrate that SPINK1 knockdown in 22RV1 attenuates invasion, suggesting a functional role in ETS rearrangement-negative prostate cancers.
first_indexed 2024-03-06T23:35:23Z
format Journal article
id oxford-uuid:6d7b10a8-2394-46e7-9cac-22b4d4802093
institution University of Oxford
language English
last_indexed 2024-03-06T23:35:23Z
publishDate 2008
record_format dspace
spelling oxford-uuid:6d7b10a8-2394-46e7-9cac-22b4d48020932022-03-26T19:18:07ZThe role of SPINK1 in ETS rearrangement-negative prostate cancers.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6d7b10a8-2394-46e7-9cac-22b4d4802093EnglishSymplectic Elements at Oxford2008Tomlins, SARhodes, DRYu, JVarambally, SMehra, RPerner, SDemichelis, FHelgeson, BLaxman, BMorris, DCao, QCao, XAndrén, OFall, KJohnson, LWei, JShah, RAl-Ahmadie, HEastham, JEggener, SEFine, SHotakainen, KStenman, UTsodikov, AGerald, WETS gene fusions have been characterized in a majority of prostate cancers; however, the key molecular alterations in ETS-negative cancers are unclear. Here we used an outlier meta-analysis (meta-COPA) to identify SPINK1 outlier expression exclusively in a subset of ETS rearrangement-negative cancers ( approximately 10% of total cases). We validated the mutual exclusivity of SPINK1 expression and ETS fusion status, demonstrated that SPINK1 outlier expression can be detected noninvasively in urine, and observed that SPINK1 outlier expression is an independent predictor of biochemical recurrence after resection. We identified the aggressive 22RV1 cell line as a SPINK1 outlier expression model and demonstrate that SPINK1 knockdown in 22RV1 attenuates invasion, suggesting a functional role in ETS rearrangement-negative prostate cancers.
spellingShingle Tomlins, SA
Rhodes, DR
Yu, J
Varambally, S
Mehra, R
Perner, S
Demichelis, F
Helgeson, B
Laxman, B
Morris, D
Cao, Q
Cao, X
Andrén, O
Fall, K
Johnson, L
Wei, J
Shah, R
Al-Ahmadie, H
Eastham, J
Eggener, SE
Fine, S
Hotakainen, K
Stenman, U
Tsodikov, A
Gerald, W
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title_full The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title_fullStr The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title_full_unstemmed The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title_short The role of SPINK1 in ETS rearrangement-negative prostate cancers.
title_sort role of spink1 in ets rearrangement negative prostate cancers
work_keys_str_mv AT tomlinssa theroleofspink1inetsrearrangementnegativeprostatecancers
AT rhodesdr theroleofspink1inetsrearrangementnegativeprostatecancers
AT yuj theroleofspink1inetsrearrangementnegativeprostatecancers
AT varamballys theroleofspink1inetsrearrangementnegativeprostatecancers
AT mehrar theroleofspink1inetsrearrangementnegativeprostatecancers
AT perners theroleofspink1inetsrearrangementnegativeprostatecancers
AT demichelisf theroleofspink1inetsrearrangementnegativeprostatecancers
AT helgesonb theroleofspink1inetsrearrangementnegativeprostatecancers
AT laxmanb theroleofspink1inetsrearrangementnegativeprostatecancers
AT morrisd theroleofspink1inetsrearrangementnegativeprostatecancers
AT caoq theroleofspink1inetsrearrangementnegativeprostatecancers
AT caox theroleofspink1inetsrearrangementnegativeprostatecancers
AT andreno theroleofspink1inetsrearrangementnegativeprostatecancers
AT fallk theroleofspink1inetsrearrangementnegativeprostatecancers
AT johnsonl theroleofspink1inetsrearrangementnegativeprostatecancers
AT weij theroleofspink1inetsrearrangementnegativeprostatecancers
AT shahr theroleofspink1inetsrearrangementnegativeprostatecancers
AT alahmadieh theroleofspink1inetsrearrangementnegativeprostatecancers
AT easthamj theroleofspink1inetsrearrangementnegativeprostatecancers
AT eggenerse theroleofspink1inetsrearrangementnegativeprostatecancers
AT fines theroleofspink1inetsrearrangementnegativeprostatecancers
AT hotakainenk theroleofspink1inetsrearrangementnegativeprostatecancers
AT stenmanu theroleofspink1inetsrearrangementnegativeprostatecancers
AT tsodikova theroleofspink1inetsrearrangementnegativeprostatecancers
AT geraldw theroleofspink1inetsrearrangementnegativeprostatecancers
AT tomlinssa roleofspink1inetsrearrangementnegativeprostatecancers
AT rhodesdr roleofspink1inetsrearrangementnegativeprostatecancers
AT yuj roleofspink1inetsrearrangementnegativeprostatecancers
AT varamballys roleofspink1inetsrearrangementnegativeprostatecancers
AT mehrar roleofspink1inetsrearrangementnegativeprostatecancers
AT perners roleofspink1inetsrearrangementnegativeprostatecancers
AT demichelisf roleofspink1inetsrearrangementnegativeprostatecancers
AT helgesonb roleofspink1inetsrearrangementnegativeprostatecancers
AT laxmanb roleofspink1inetsrearrangementnegativeprostatecancers
AT morrisd roleofspink1inetsrearrangementnegativeprostatecancers
AT caoq roleofspink1inetsrearrangementnegativeprostatecancers
AT caox roleofspink1inetsrearrangementnegativeprostatecancers
AT andreno roleofspink1inetsrearrangementnegativeprostatecancers
AT fallk roleofspink1inetsrearrangementnegativeprostatecancers
AT johnsonl roleofspink1inetsrearrangementnegativeprostatecancers
AT weij roleofspink1inetsrearrangementnegativeprostatecancers
AT shahr roleofspink1inetsrearrangementnegativeprostatecancers
AT alahmadieh roleofspink1inetsrearrangementnegativeprostatecancers
AT easthamj roleofspink1inetsrearrangementnegativeprostatecancers
AT eggenerse roleofspink1inetsrearrangementnegativeprostatecancers
AT fines roleofspink1inetsrearrangementnegativeprostatecancers
AT hotakainenk roleofspink1inetsrearrangementnegativeprostatecancers
AT stenmanu roleofspink1inetsrearrangementnegativeprostatecancers
AT tsodikova roleofspink1inetsrearrangementnegativeprostatecancers
AT geraldw roleofspink1inetsrearrangementnegativeprostatecancers